Home > Insider Trading > Filing (0001104659-24-068675)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773427	Springworks Therapeutics Inc.	SWTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575408	Saqib Islam	C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-06-03	33,240	$39.40	1,128,128	No	4	S	Direct
Common Stock	Disposition	2024-06-03	8,760	$40.57	1,119,368	No	4	S	Direct
Common Stock	Disposition	2024-06-03	6,600	$41.40	1,112,768	No	4	S	Direct
Common Stock	Disposition	2024-06-03	400	$42.09	1,112,368	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.02 to $40.0147. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $41.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.0332 to $42.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Due to an administrative error, the prior Form 4 underreported total ownership by 905,104 shares, but total ownership has been corrected in this Form 4. No reportable transaction was omitted from such filing.